Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
The QMN Weekly Bulletin
> J&J Recalling Pain Patch
The QMN Weekly Bulletin
Feb. 15, 2008
| Vol. 2 No. 7
J&J Recalling Pain Patch
Johnson & Johnson is voluntarily recalling a version of its blockbuster pain patch Duragesic because of manufacturing issues that could lead to accidental overdoses.
The Wall Street Journal
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Maker of Radioactive Needle Sets Warned Over Complaint Handling
Compounders Counter FDA Call for More Inspection Authority
Ranbaxy Settles cGMP Case With DOJ
Genentech Finds Particulates in Some Vials of Blood Clot Drug